Report overview
The FDA defines decentralized clinical trials as those executed through telemedicine and mobile or local healthcare providers, using processes and technologies that differ from the traditional clinical trial model.
Decentralized clinical trials are conducted remotely, with patient subjects remaining at home during a significant portion, or all, of the study. However, the decentralized clinical trial model is designed for more just patient participants.
This report aims to provide a comprehensive presentation of the global market for Decentralized Clinical Trials (DCTs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decentralized Clinical Trials (DCTs). This report contains market size and forecasts of Decentralized Clinical Trials (DCTs) in global, including the following market information:
Global Decentralized Clinical Trials (DCTs) Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Decentralized Clinical Trials (DCTs) market was valued at US$ 7341.6 million in 2022 and is projected to reach US$ 9245.9 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Decentralized Clinical Trials (DCTs) key players include Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, etc. Global top five manufacturers hold a share over 45%.
North America is the largest production region, with a share about 60%, followed by Europe and Asia-Pacific, both have a share over 30 percent. In terms of product, Interventional is the largest segment, with a share over 45%. And in terms of application, the largest application is Oncology, followed by Cardiovascular, etc.
We surveyed the Decentralized Clinical Trials (DCTs) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Decentralized Clinical Trials (DCTs) Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Decentralized Clinical Trials (DCTs) Market Segment Percentages, by Type, 2022 (%)
Interventional Trials
Observational Trials
Expanded Access Trials
Global Decentralized Clinical Trials (DCTs) Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Decentralized Clinical Trials (DCTs) Market Segment Percentages, by Application, 2022 (%)
Oncology
Cardiovascular Disease
Others
Global Decentralized Clinical Trials (DCTs) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Decentralized Clinical Trials (DCTs) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Decentralized Clinical Trials (DCTs) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Decentralized Clinical Trials (DCTs) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ICON Plc
LEO Innovation Lab
Science 37
PRA Health Sciences
Clinical Ink
Parexel
Medable
Oracle
CRF Health
Medidata
Covance
IQVIA
PPD
PWNHealth, LLC
Medrio
Outline of Major Chapters:
Chapter 1: Introduces the definition of Decentralized Clinical Trials (DCTs), market overview.
Chapter 2: Global Decentralized Clinical Trials (DCTs) market size in revenue.
Chapter 3: Detailed analysis of Decentralized Clinical Trials (DCTs) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Decentralized Clinical Trials (DCTs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
